# Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

> **NCT04457089** · EARLY_PHASE1 · COMPLETED · sponsor: **Marc Goodman** · enrollment: 18 (actual)

## Conditions studied

- Recurrent Ovarian Cancer
- Platinum-sensitive Ovarian Cancer

## Interventions

- **DRUG:** Simvastatin 40mg

## Key facts

- **NCT ID:** NCT04457089
- **Lead sponsor:** Marc Goodman
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-25
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-05-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457089, "Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04457089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*